Prostate‐specific membrane antigen‐based imaging in prostate cancer: Impact on clinical decision making process

Abstract

PSMA based nuclear imaging has significantly impacted our way of handling patients with prostate cancer. Its preliminary performance in different clinical scenarios and ability to detect lesions even in low PSA values seems fairly promising and deserves to be supplemented with further clinical studies.